NCT07261241
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07261241
Title NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors New Approaches to Neuroblastoma Therapy Consortium
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90027-0700 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94143 United States Details
Children Hospital of Colorado Aurora Colorado 80045 United States Details
Children's Healthcare of Atlanta Atlanta Georgia 30322 United States Details
Children's Memorial Hospital - Chicago Chicago Illinois 60614 United States Details
Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston Massachusetts 02115 United States Details
C.S Mott Children's Hospital Ann Arbor Michigan 48109 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229-3039 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104-4318 United States Details
St. Jude Children's Research Hospital Memphis Tennessee 38105 United States Details
University of Texas Southwestern Dallas Texas 75235 United States Details
Cook Children's Medical Center - Fort Worth Fort Worth Texas 76104 United States Details
Children's Hospital and Regional Medical Center - Seattle Seattle Washington 98105 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field